Related Experiment Video

Updated: Nov 19, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.0K

[Standardized treatment of low-risk acute myeloid leukemia]

F F Tang1, X J Huang1

  • 1National Clinical Research Center for Hematologic Disease, Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.

Zhonghua Nei Ke Za Zhi
|January 27, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

251
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.4K

Related Experiment Videos

Last Updated: Nov 19, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.0K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

251
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.4K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

638
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
638

Articles linked to this work by shared authors, journal, and citation graph.

[Impact of recipient age on outcomes of allogeneic hematopoietic stem cell transplantation: an analysis from the Chinese Bone Marrow Transplant Registry Group (CBMTRG)].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

[The causes of death in elderly patients undergoing haploidentical stem cell transplantation].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

[Prognostic analysis of NUP98 rearrangement in patients with pediatric acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

[Efficacy and safety of basiliximab in gastrointestinal chronic graft-versus-host disease].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

[Secondary treatment-free remission in chronic myeloid leukemia in the chronic phase: a case series and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

[Advances in the prevention and treatment of acute graft-versus-host disease with cellular and novel targeted immunotherapy].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

[A case of paraganglioma-related catecholamine-induced cardiomyopathy manifesting as dilated cardiomyopathy and literature review].

Zhonghua nei ke za zhi·2026

[Clinical analysis of two cases of 11β-hydroxylase deficiency diagnosed after adrenal mass resection].

Zhonghua nei ke za zhi·2026

[A novel CYP19A1 variant causing aromatase deficiency in a family: case report and literature review].

Zhonghua nei ke za zhi·2026

[Comparison of cecal ligation and puncture versus intraperitoneal lipopolysaccharide injection-induced animal models of sepsis-associated acute kidney injury].

Zhonghua nei ke za zhi·2026

[Analysis of clinical spectrum and genotype characteristics of 9 cases of Fabry disease].

Zhonghua nei ke za zhi·2026

[Alterations in olfactory and spatial navigation abilities and their neural mechanisms in subjective cognitive decline: an fMRI study].

Zhonghua nei ke za zhi·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us